BMJ in UK BMJ India BMJ Brazil BMJ in North America BMJ China

New Editor for Annals of the Rheumatic Diseases

New Editor for Annals of the Rheumatic Diseases

BMJ, a leading healthcare knowledge provider, is pleased to announce Josef Smolen as the new editor of Annals of the Rheumatic Diseases (ARD).

ARD is the top ranked journal in the field of rheumatology with an impact factor of 12.811.

Josef Smolen is Professor of Medicine and Chairman of the Division of Rheumatology and Department of Medicine at the Medical University of Vienna, as well as Chairman of the Department of Medicine at Hietzing Hospital, Vienna.

He received his MD degree from the Medical University of Vienna, Austria, and trained there in immunology and medicine before serving as a research fellow at the National Institute of Health, Bethesda, MD, USA.

An accomplished author of several hundred original publications and lead investigator of many clinical trials, his scientific interests cover basic and translational research, outcomes and epidemiologic research, as well as novel therapies in rheumatic diseases.

He has also served as President of the European League Against Rheumatism (EULAR) and the Austrian Rheumatology and Immunology Societies.

Professor Smolen will take over as editor from Tore K Kvien from 1 September 2017. ARD is the official journal of EULAR reflecting the whole field of rheumatology. The journal has been co-owned by EULAR and BMJ for the past 18 years.

Professor Smolen says: “Annals of the Rheumatic Diseases has a reputation for publishing the highest standards of scientific exchange and education across all aspects of rheumatology. I plan to build on the many accomplishments of Tore K Kvien and continue to develop the academic credibility, educational profile, and strong international reputation of the journal.”

EULAR welcomes Josef Smolen to its journal, The Annals of the Rheumatic Diseases, and looks forward to further developing the journal's key contribution to the area of rheumatology. EULAR would like to thank Tore Kvien for his outstanding contribution to the journal. The journal is a means of helping to achieve excellence in science and research, and, crucially, it makes a significant contribution to the lives of millions of people the world over who suffer from RMDs.

Allison Lang, Publishing Director at BMJ, says: "We are delighted to appoint Josef Smolen to lead one of BMJ’s most influential specialist journals. Josef brings a wealth of experience. He is an internationally respected clinician and academician, who shares our vision for advancing the growing academic reputation of the journal, and maintaining its relevance to healthcare professionals worldwide.  I’d also like to thank Tore K Kvien for the commitment, expertise and enthusiasm that he brought to the role over the past 9 years.”


Note to Editors
For further information, please contact BMJ’s media relations team: / +44 (0)20 7383 6529

About the journal Annals of the Rheumatic Diseases (ARD) is a leading international journal that reflects the whole field of rheumatology. This includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. It is one of the 60 specialist journals published by BMJ. For more information, visit:

About BMJ BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. For a full list of BMJ products and services, please visit

About EULAR The European League against Rheumatism (EULAR) is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the burden of RMDs on individuals and society and to improve the treatment, prevention and rehabilitation of RMDs. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with RMDs by the EU institutions through advocacy action.


Latest coverage of BMJ in the national and international media



If you are a journalist who would like to receive our press releases, please provide your details.



Email the UK media relations team for more information.